What does CENTRE DE SENOLOGIE DE LOVERVAL do?

CENTRE DE SENOLOGIE DE LOVERVAL is a specialist medical practice in Gerpinnes. Private Limited, started on 23 December 2005, 1 establishment.

What is the address of CENTRE DE SENOLOGIE DE LOVERVAL?

The registered office of CENTRE DE SENOLOGIE DE LOVERVAL is located at Drève des Dominicains(LOV) 24, 6280 Gerpinnes.

Is CENTRE DE SENOLOGIE DE LOVERVAL still active?

Yes. According to the CBE (31 October 2026) CENTRE DE SENOLOGIE DE LOVERVAL is active, legal situation “Normale toestand”, started on 23 December 2005.

Is CENTRE DE SENOLOGIE DE LOVERVAL registered on Peppol?

No, CENTRE DE SENOLOGIE DE LOVERVAL is currently not registered on the Peppol network.

What is the enterprise number of CENTRE DE SENOLOGIE DE LOVERVAL?

The enterprise number of CENTRE DE SENOLOGIE DE LOVERVAL is BE0878156836.

When was CENTRE DE SENOLOGIE DE LOVERVAL founded?

CENTRE DE SENOLOGIE DE LOVERVAL was founded on 23 December 2005.

Who are the directors of CENTRE DE SENOLOGIE DE LOVERVAL?

According to the 2026 annual accounts, the directors of CENTRE DE SENOLOGIE DE LOVERVAL are: SRL L'IMAGERIE MEDICALE, SRL I.R. MEDICALE.

Is CENTRE DE SENOLOGIE DE LOVERVAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 2005; 5 annual accounts filed, latest fiscal year 2026; 2 directors known from the annual account.

How much profit did CENTRE DE SENOLOGIE DE LOVERVAL make in 2026?

CENTRE DE SENOLOGIE DE LOVERVAL posted a profit after taxes of € 484 in financial year 2026.

What is the revenue of CENTRE DE SENOLOGIE DE LOVERVAL?

As a small company, CENTRE DE SENOLOGIE DE LOVERVAL is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 135,892.

CENTRE DE SENOLOGIE DE LOVERVAL (Private Limited)

Dossier CENTRE DE SENOLOGIE DE LOVERVAL, printed on 1 November 2026 from databakkes.be/en/0878156836/centre-de-senologie-de-loverval. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2026

CENTRE DE SENOLOGIE DE LOVERVAL from Gerpinnes, company number BE0878156836, closed financial year 2026 with a result of € 484 after tax. For that financial year CENTRE DE SENOLOGIE DE LOVERVAL recorded a gross margin of € 135,892 and equity of € 28,494. Compared with financial year 2025, the result moved from € 12 to € 484. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2026.

What it is worth Growing

€ 28,494

▲ 2% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 484

▲ € 471 vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 288,424

▲ 45% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 494.

People and assets in 2026

Wage cost

€ 128,783

▲ 5% vs 2025

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,053

▼ 62% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 225,655

€ 31,426 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 255,993

▲ 34% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 22,895

▲ 9% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 113,042 Gross margin 2023: € 113,042 First fiscal year in the series	€ 113,905 Gross margin 2024: € 113,905 ▲ 1% vs 2023 (€ 113,042) Favourable step	€ 123,945 Gross margin 2025: € 123,945 ▲ 9% vs 2024 (€ 113,905) Favourable step	€ 135,892 Gross margin 2026: € 135,892 ▲ 10% vs 2025 (€ 123,945) Favourable step	▲ 10%
Profit after taxes	€ -178 Profit after taxes 2023: € -178 First fiscal year in the series	€ 144 Profit after taxes 2024: € 144 ▲ € 322 vs 2023 (€ -178) Favourable step	€ 12 Profit after taxes 2025: € 12 ▼ 92% vs 2024 (€ 144) Unfavourable step	€ 484 Profit after taxes 2026: € 484 ▲ € 471 vs 2025 (€ 12) Favourable step	▲ € 471
Equity	€ 27,854 Equity 2023: € 27,854 First fiscal year in the series	€ 27,998 Equity 2024: € 27,998 ▲ 1% vs 2023 (€ 27,854) Favourable step	€ 28,010 Equity 2025: € 28,010 Unchanged (€ 27,998) Favourable step	€ 28,494 Equity 2026: € 28,494 ▲ 2% vs 2025 (€ 28,010) Favourable step	▲ 2%
Total debts	€ 175,711 Total debts 2023: € 175,711 First fiscal year in the series	€ 215,799 Total debts 2024: € 215,799 ▲ 23% vs 2023 (€ 175,711) Unfavourable step	€ 212,756 Total debts 2025: € 212,756 ▼ 1% vs 2024 (€ 215,799) Favourable step	€ 504,544 Total debts 2026: € 504,544 ▲ 137% vs 2025 (€ 212,756) Unfavourable step	▲ 137%
Cash	€ 170,383 Cash 2023: € 170,383 First fiscal year in the series	€ 207,189 Cash 2024: € 207,189 ▲ 22% vs 2023 (€ 170,383) Favourable step	€ 199,323 Cash 2025: € 199,323 ▼ 4% vs 2024 (€ 207,189) Unfavourable step	€ 288,424 Cash 2026: € 288,424 ▲ 45% vs 2025 (€ 199,323) Favourable step	▲ 45%
Retained profit	€ -146 Retained profit 2023: € -146 First fiscal year in the series	€ -2 Retained profit 2024: € -2 ▲ € 144 vs 2023 (€ -146) Favourable step	€ 10 Retained profit 2025: € 10 ▲ € 12 vs 2024 (€ -2) Favourable step	€ 494 Retained profit 2026: € 494 ▲ € 484 vs 2025 (€ 10) Favourable step	▲ € 484
Bank debt	€ 0 Bank debt 2023: € 0 First fiscal year in the series	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged	€ 225,655 Bank debt 2026: € 225,655 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 203,565 Balance sheet total 2023: € 203,565 First fiscal year in the series	€ 243,796 Balance sheet total 2024: € 243,796 ▲ 20% vs 2023 (€ 203,565) Unchanged	€ 240,766 Balance sheet total 2025: € 240,766 ▼ 1% vs 2024 (€ 243,796) Unchanged	€ 533,037 Balance sheet total 2026: € 533,037 ▲ 121% vs 2025 (€ 240,766) Unchanged	▲ 121%

Key figures of CENTRE DE SENOLOGIE DE LOVERVAL, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to CENTRE DE SENOLOGIE DE LOVERVAL?

What happened at CENTRE DE SENOLOGIE DE LOVERVAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 24, 2026 New annual accounts for financial year 2026: profit of € 484 (▲ € 471 vs 2025). Source: NBB ↗
2023 SRL L'IMAGERIE MEDICALE became a director. NBB
2023 SRL I.R. MEDICALE became a director. NBB
Nov 1, 2012 New establishment in Gerpinnes. KBO
Dec 23, 2005 Start of the company according to the CBE. KBO

In short

From € 178 loss in 2023 to € 484 profit in 2026.

Paid € 2,443 in corporate taxes since 2023.

Best year ever: 2026, with € 484 profit.

Original PDFs at the National Bank ↗

Management

I.R. MEDICALE 50%

The stake of I.R. MEDICALE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

CENTRE DE SENOLOGIE DE LOVERVAL

Behind CENTRE DE SENOLOGIE DE LOVERVAL are SRL L'IMAGERIE MEDICALE and SRL I.R. MEDICALE. The shares are held by I.R. MEDICALE (50%).

Directors

According to the 2026 annual accounts

SRL L'IMAGERIE MEDICALE

Director · represented by Myriam Littani

since 2023

SRL I.R. MEDICALE

Director · represented by Isabelle Rousseau

since 2023

Shareholders

I.R. MEDICALE

50%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Drève des Dominicains(LOV) 24

6280 Gerpinnes

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Institut de Pharmacologie et d'Investigations Biomedicales

SOCIETE MEDICALE DU DOCTEUR CUVELIER PIERRE

€ 198,360 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0878.156.836

VAT number

BE 0878.156.836

Registered office

Drève des Dominicains(LOV) 24, 6280 Gerpinnes

Names & denominations

CENTRE DE SENOLOGIE DE LOVERVAL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 December 2005

Peppol

Not registered

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

CENTRE DE SENOLOGIE DE LOVERVAL

Warning lights

Financials

What happened to CENTRE DE SENOLOGIE DE LOVERVAL?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions